Nationwide COVID-19 vaccination coverage and COVID-19 incidence in South Korea, January 2022: a national official report
Author:
Funder
National Research Foundation of Korea
Publisher
Life Cycle
Link
http://www.elifecycle.org/download/download_pdf?doi=10.54724/lc.2022.e2
Reference25 articles.
1. Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort;Lee;Gut,2021
2. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020;Oliver;MMWR Morb Mortal Wkly Rep.,2020
3. The advisory committee on immunization practices' interim recommendation for use of Moderna COVID-19 Vaccine - United States, December 2020;Oliver;MMWR Morb Mortal Wkly Rep.,2021
4. The advisory committee on immunization practices' interim recommendation for use of Janssen COVID-19 Vaccine - United States, February 2021;Oliver;MMWR Morb Mortal Wkly Rep.,2021
5. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med.,2020
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study;JMIR Public Health and Surveillance;2024-08-27
2. National and Regional Trends in the Prevalence of Hypertension in South Korea Amid the Pandemic, 2009-2022: Nationwide Study of Over 3 Million Individuals;JMIR Public Health and Surveillance;2024-07-30
3. National trends in counseling for stress and depression and COVID-19 pandemic-related factors among adults, 2009–2022: A nationwide study in South Korea;Psychiatry Research;2024-07
4. Impact of COVID-19 pandemic on neurodevelopmental outcomes of premature infants: a retrospective national cohort study;BMJ Paediatrics Open;2024-05
5. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study (Preprint);2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3